Management of Secondary-Progressive Multiple Sclerosis

被引：0
作者：
Gavin Giovannoni
机构：
[1] The National Hospital for Neurology and Neurosurgery,Department of Neuroinflammation, Institute of Neurology
来源：
CNS Drugs | 2004年 / 18卷
关键词：
Multiple Sclerosis; Multiple Sclerosis Patient; Mitoxantrone; Expand Disability Status Scale; Glatiramer Acetate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The majority of patients with relapse-onset multiple sclerosis (MS) will go on to develop secondary-progressive MS (SPMS) disease, with approximately 50% developing SPMS after 10 years. It remains unknown whether the relapsing and progressive phases of MS differ qualitatively. The pathogenesis of SPMS is poorly understood. The specific role that inflammation plays in disease progression is not well defined.
引用
收藏
页码：653 / 669
页数：16
相关论文
共 281 条
[1]  
Sawcer S(2002)A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility Brain 125 1337-47
[2]  
Maranian M(1993)Epidemiologic evidence for multiple sclerosis as an infection Clin Microbiol Rev 6 382-427
[3]  
Setakis E(1989)The natural history of multiple sclerosis: a geographically based study I: clinical course and disability. Brain 112 133-46
[4]  
Kurtzke JF(2000)Diagnostic criteria for primary progressive multiple sclerosis: a position Ann Neurol 47 831-5
[5]  
Weinshenker BG(1999)Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors J Neurol Neurosurg Psychiatry 67 148-52
[6]  
Bass B(2003)Multiple paradigm shifts in multiple sclerosis Curr Opin Neurol 16 247-52
[7]  
Rice GP(1996)Assessing efficacy in clinical trials of treatments for multiple sclerosis: issues and controversy CNS Drugs 6 462-73
[8]  
Thompson AJ(2000)Autoimmunity can benefit self-maintenance Immunol Today 21 265-8
[9]  
Montalban X(2002)Maneuvering in the complex path from genotype to phenotype Science 296 701-3
[10]  
Barkhof F(2002)Complex disease and the new clinical sciences Science 296 698-700
12345678910